Xcout Intel
Qiagen N.V. Common Shares
Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, inclsuing assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables comprising short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; DNA methylation analysis; QIAGEN consumables and instruments; bioinformatics solutions; and sequence-based assays forensic genetic genealog services. it provides software-as-a-service. It serves molecular diagnostics and life sciences sectors. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.
Subscribe to see Qiagen N.V. Common Shares’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Qiagen N.V. Common Shares at a glance
Qiagen N.V. Common Shares is a medical - diagnostics & research company headquartered in Venlo, Netherlands. It is publicly listed (QGEN) with a market capitalisation of $9.2B. Xcout tracks 12 named people at Qiagen N.V. Common Shares, including Jonathan Pratt (CEO & Member of Management Board). Xcout recorded 163 job postings from Qiagen N.V. Common Shares in the last 90 days, naming tools such as SAP, Salesforce, Model Context Protocol.
Qiagen N.V. Common Shares leadership
- Jonathan PrattCEO & Member of Management Board
- Roland SackersChief Financial Officer, MD & Member of Management Board
- Antonio SantosSenior Vice President & Head of Global Operations
- Jean-Pascal ViolaSenior Vice President & Head of Corporate Strategy and Business Development
- Stephany FosterSenior Vice President & Head of Human Resources
- Thomas SchweinsSenior Vice President of Life Science Business Area
6 more named people on record for Qiagen N.V. Common Shares, with roles, board committees and tenure — see the full roster →
Hiring at Qiagen N.V. Common Shares
Xcout recorded 163 job postings from Qiagen N.V. Common Shares in the last 90 days, from a hiring record Xcout has kept since June 2026.
Tools named in Qiagen N.V. Common Shares's job postings
The weekly hiring trend, the roles and locations behind it and all 16 tools — see Qiagen N.V. Common Shares's hiring signals →
Hiring vs the trend
Based on 98 job postings in the last 8 weeks (10 Aug – 4 Oct 2026), compared with 168 enterprise healthcare companies.
This describes a hiring pattern — how often Qiagen N.V. Common Shares’s job postings ask for AI skills, and how that changed against the previous 8 weeks, ranked among its peers. It says nothing about the company’s products or performance.
Signed-in members see the AI-skill share and its change with peer percentiles, role mix, posting momentum and advertised US pay against the market.
Tech stack
Qiagen N.V. Common Shares competitors
A few of Qiagen N.V. Common Shares's closest competitors — see the full list of competitors and alternatives →
Gentra Systems, Inc. is a Minneapolis-based company that develops, manufactures, and supplies nucleic acid purification reagents, molecular-testing tools, and sample-processing technologies for research, clinical, and applied laboratory use. The company specializes in non-solid phase nucleic acid purification products for niche markets such as bio-banking and DNA archiving. Gentra Systems operates as a subsidiary of Qiagen following its acquisition.
BLIRT S.A. is an enzymes provider headquartered in Gdansk, Poland. Founded in 1994, the company operates as a subsidiary of Qiagen N.V. after QIAGEN acquired a majority stake.
Enzymatics, Inc. was a biotechnology company that developed and supplied enzymes and molecular-biology reagents, particularly for next-generation sequencing and nucleic-acid workflows. It served research, diagnostic, and life-sciences customers and was acquired by QIAGEN in 2015.
GenDx specializes in molecular diagnostics for transplantation and personalized healthcare, providing pre- and post-transplant reagents, NGS-based typing assays, and analysis software. The company serves diagnostic laboratories, transplant centers, and researchers by offering products and technical support for HLA typing, chimerism monitoring, and related applications.
Illumina, Inc. specializes in delivering advanced sequencing and array technologies designed for genetic and genomic examination. These offerings cater to a diverse array of markets, fostering the widespread use of genomic insights across both research laboratories and clinical environments. Key application areas include life sciences, cancer diagnostics, reproductive medicine, agricultural science, and various nascent fields. The company's portfolio encompasses specialized instrumentation and associated consumables vital for genetic analysis. Additionally, it offers comprehensive genotyping and sequencing services, extends instrument maintenance contracts, and engages in development and licensing partnerships, alongside providing cancer screening services. Illumina's client base is extensive, comprising genomic research facilities, universities, state-funded laboratories, and healthcare providers. It also serves pharmaceutical firms, biotechnology companies, commercial molecular diagnostics providers, and businesses focused on consumer genomics. Globally, Illumina distributes its products through direct sales channels in North America, Europe, Latin America, and the Asia-Pacific. Furthermore, it leverages third-party life-science distributors to reach markets across Europe, the Asia-Pacific, Latin America, the Middle East, and Africa. Established in 1998, the company maintains its corporate headquarters in San Diego, California.
IntegraGen develops genomic tests, molecular diagnostic products, and bioinformatics software for researchers, clinicians, and biopharma companies. The company specializes in oncology and genetic diseases, offering next-generation sequencing services, data analysis tools, and biomarker identification to support clinical research and diagnostics.
Get Qiagen N.V. Common Shares's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Qiagen N.V. Common Shares in Xcout Intel
- 12 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access